SCHEMBL25934033

SCHEMBL25934033

c1cc2cn[nH]c2cc1N1CCC2(CC1)OCCO2

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LGMN Q99538 1/20 0.49
▸ SYK P43405 11/20 0.45
▸ BTK Q06187 5/20 0.45
▸ PDGFRB P09619 2/20 0.44
▸ PDGFRA P16234 2/20 0.44
▸ JAK2 O60674 1/20 0.40
▸ NTRK1 P04629 1/20 0.40
▸ ROS1 P08922 1/20 0.40
▸ CSNK2A2 P19784 1/20 0.40
▸ FLT3 P36888 1/20 0.40
▸ CSNK2B P67870 1/20 0.40
▸ CSNK2A1 P68400 1/20 0.40
▸ PTK6 Q13882 1/20 0.40
▸ CSNK2A3 Q8NEV1 1/20 0.40
▸ NOS1 P29475 2/20 0.40
▸ DYRK1A Q13627 2/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ MAPT P10636 1/20 0.40
▸ PKM P14618 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29728069 0.83 SYK (0.59) SYKBTKPDGFRBPDGFRAJAK2
SCHEMBL18399012 0.83 SYK (0.59) SYKBTKPDGFRBPDGFRAJAK2
SCHEMBL30837522 0.82 NOS1 (0.52) SYKBTKPDGFRBPDGFRANOS1
SCHEMBL29039315 0.79 NOS1 (0.49) SYKBTKPDGFRBPDGFRANOS1
SCHEMBL30385421 0.79 NOS1 (0.49) SYKBTKPDGFRBPDGFRANOS1
SCHEMBL30469212 0.78 TERT (0.53) SYKBTKPDGFRBPDGFRANOS1
SCHEMBL29539832 0.77 PDGFRB (0.55) SYKBTKPDGFRBPDGFRANOS1
SCHEMBL2799745 0.77 PDGFRB (0.55) SYKBTKPDGFRBPDGFRANOS1
SCHEMBL5095062 0.76 FGFR1 (0.56) BTKPDGFRBPDGFRAJAK2NTRK1
SCHEMBL5412781 0.73 PLK4 (0.56) SYKBTKPDGFRBPDGFRAPIK3CA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023109892-A1 COMPOUND FOR INHIBITING OR DEGRADING BRD9, AND COMPOSITION AND PHARMACEUTICAL USE THEREOF 海思科医药集团股份有限公司 2023-06-22 — — WO disclosed
Send feedback